Skip to main content
SpringerLink
Log in

Perforation digestive sous anticoagulant direct

Acute abdominal surgery in a patient treated with direct oral anticoagulant

  • Cas Clinique / Case Report
  • Published:
Annales françaises de médecine d'urgence

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Références

  1. Kirchhof P, Benussi S, Kotecha D, et al (2016) 2016 ESC Guidelines for the management of atrial fibrillation. Eur Heart J 37:2893–962

    Article  PubMed  Google Scholar 

  2. Camm AJ, Lip GYH, De Caterina R, et al (2012) 2012 focused update of the ESC guidelines for the management of atrial fibrillation. Eur Heart J 33:2719–47

    Article  PubMed  Google Scholar 

  3. Bancroft T, Lim J, Wang C, et al (2016) Health care resource utilization, costs, and persistence in patients newly diagnosed as having nonvalvular atrial fibrillation and newly treated with dabigatran versus warfarin in the United States. Clin Ther 38:545–56

    Article  PubMed  Google Scholar 

  4. Nielsen PB, Skjøth F, Søgaard M, et al (2017) Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study. BMJ 356:j510

    Article  PubMed  Google Scholar 

  5. Pernod G, Albaladejo P, Godier A, et al (2013) Prise en charge des complications hémorragiques graves et de la chirurgie en urgence chez les patients recevant un anticoagulant oral anti-IIa ou anti-Xa direct. Propositions du Groupe d’intérêt en Hémostase Périopératoire (GIHP)- mars 2013. Ann Fr Anesth Reanim 32:691–700

    Article  CAS  PubMed  Google Scholar 

  6. Godier A, Martin AC, Leblanc I, et al (2010) Peri-procedural management of dabigatran and rivaroxaban: duration of anticoagulant discontinuation and drug concentrations. Thromb Haemost 103:1116–27

    Article  Google Scholar 

  7. Heidbuchel H, Verhamme P, Alings P, et al (2013) European Heart Rhythm Association practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation Europace 15:625–51

    Article  PubMed  Google Scholar 

  8. Albaladejo P, Pernod G, Godier A, et al (2016) Prise en charge des hémorragies et des gestes invasifs urgents chez les patients recevant un anticoagulant oral et direct anti-IIa (dabigatran). Réactualisation des propositions du Groupe d’Intérêt en Hémostase Périopératoire (GIHP)- septembre 2016. http://site.geht.org/ UserFiles/file/NACO/nouvelles_propositions_GIHP_urgences_- dabigatran_septembre2016.pdf (Dernier accès le 4 mai 2017)

    Google Scholar 

  9. Zahir H, Brown KS, Vandell AG, et al (2015) Edoxaban effects on bleeding following punch biopsy and reversal by a 4-factor prothrombin complex concentrate. Circulation 131:82–90

    Article  CAS  PubMed  Google Scholar 

  10. Connolly SJ, Milling TJ Jr, Eikelboom JW, et al (2016) Andexanet alfa for acute major bleeding associated with factor Xa inhibitors. N Engl J Med 375:1131–41

    Article  CAS  PubMed  Google Scholar 

  11. Ansell JE, Bakhru SH, Laulicht BE, et al (2014) Use of PER977 to reverse the anticoagulant effect of edoxaban. N Engl J Med 371:2141–2

    Article  PubMed  Google Scholar 

  12. Pollack CV Jr, Reilly AP, Eikelboom J, et al (2015) Idarucizumab for dabigatran reversal. N Engl J Med 373:511–20

    Article  CAS  PubMed  Google Scholar 

  13. Quintard H, Viard D, Drici MD, et al (2017) Idarucizumab administration for reversing dabigatran effect in an acute kidney injured patient with bleeding. Thromb Haemost 117:196–7

    Article  PubMed  Google Scholar 

  14. Sauter TC, Blum S, Nagler M, et al (2016) Reversal of dabigatran using idarucizumab in a septic patient with impaired kidney function in real-life practice. Case Rep Emerg Med 2016:1393057

    PubMed  PubMed Central  Google Scholar 

  15. Hofer S, Philipsenburg C, Weigand MA, Brenner T (2016) Reversal of anticoagulation with dabigatran in an 82-year-old patient with traumatic retroperitoneal arterial bleeding using the new antidote idarucizumab: a case report. A A Case Rep 7:227–31

    Article  PubMed  Google Scholar 

  16. Held V, Eisele P, Eschenfelder CC, Szabo K (2016) Idarucizumab as antidote to intracerebral hemorrhage under treatment with dabigatran. Case Rep Neurol 8:224–8

    Article  PubMed  PubMed Central  Google Scholar 

  17. Peetermans M, Pollack C Jr, Reilly P, et al (2016) Idarucizumab for dabigatran overdose. Clin Toxicol 54:644–6

    Article  Google Scholar 

  18. Shapiro S, Bhatnagar N, Khan A, et al (2016) Idarucizumab for dabigatran overdose in a child. Br J Haematol [in press]

    Google Scholar 

  19. Schäfer N, Müller A, Wüllner U (2016) Systemic thrombolysis for ischemic stroke after antagonizing dabigatran with idarucizumab-A case report. J Stroke Cerebrovasc Dis 25:e126–7

    Article  Google Scholar 

  20. Berrouschot J, Stoll A, Hogh T, Eschenfelder CC (2016) Intravenous thrombolysis with recombinant tissue-type plasminogen Aactivator in a stroke patient receiving dabigatran anticoagulant after antagonization with idarucizumab. Stroke 47:1936–8

    Article  CAS  PubMed  Google Scholar 

  21. Scappaticci F, Skillings J, Holden S, et al (2007) Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab. J Natl Cancer Inst 99:1232–9

    Article  PubMed  Google Scholar 

  22. Zhu X, Tian X, Yu C, et al (2016) Increased risk of hemorrhage in metastatic colorectal cancer patients treated with bevacizumab: An updated meta-analysis of 12 randomized controlled trials. Medicine 95:e4232.

    Article  Google Scholar 

  23. Bosscha K, Reijnders K, Hulstaert PF, et al (1997) Prognostic scoring systems to predict outcome in peritonitis and intraabdominal sepsis. J Surg 84:1532–4

    CAS  Google Scholar 

  24. Gould MK, Garcia DA, Wren SM, et al (2012) Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis. 9th edn: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 14:e227S–77S

    Article  Google Scholar 

  25. Harrison MH, Edwards RJ, Graveney MJ, et al (1981) Blood volume and plasma protein responses to heat acclimatization in humans. J Appl Physiol Respir Environ Exerc Physiol 50:597–604

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Département de médecine d’urgence, centre hospitalier Princesse Grace, 1 avenue Pasteur, Monaco-Ville, MC-98012, Principauté de Monaco

    Y.-E. Claessens, J. Nadal & N. Beau

Authors
  1. Y.-E. Claessens
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Nadal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. Beau
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Y.-E. Claessens.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Claessens, YE., Nadal, J. & Beau, N. Perforation digestive sous anticoagulant direct. Ann. Fr. Med. Urgence 7, 197–200 (2017). https://doi.org/10.1007/s13341-017-0749-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13341-017-0749-x

Search

Navigation